Abstract
Survival of myocytes and mesenchymal cells in the heart is tightly regulated by a number of adaptive processes that are invoked with the changes that occur within the parenchyma and stroma. Autophagy is implicated in cellular housekeeping duties and maintenance of the integrity of the intracellular milieu by removal of protein aggregates and damaged organelles, whereas under pathophysiological conditions, the chronic up-regulation of autophagy may lead to significant disturbance of homeostatic conditions. Nonetheless, the role of autophagy in heart disease in the context of cardiac ischemia-reperfusion injury is currently unclear. This review will focus upon the role of autophagy as it pertains to ischemiareperfusion damage in the heart.
Keywords: Autophagy, heart, heart disease, ischemia-reperfusion, mitophagy.
Current Molecular Medicine
Title:Autophagy and Heart Disease: Implications for Cardiac Ischemia- Reperfusion Damage
Volume: 14 Issue: 5
Author(s): S. Ghavami, S. Gupta, E. Ambrose, M. Hnatowich, D.H. Freed and I.M.C. Dixon
Affiliation:
Keywords: Autophagy, heart, heart disease, ischemia-reperfusion, mitophagy.
Abstract: Survival of myocytes and mesenchymal cells in the heart is tightly regulated by a number of adaptive processes that are invoked with the changes that occur within the parenchyma and stroma. Autophagy is implicated in cellular housekeeping duties and maintenance of the integrity of the intracellular milieu by removal of protein aggregates and damaged organelles, whereas under pathophysiological conditions, the chronic up-regulation of autophagy may lead to significant disturbance of homeostatic conditions. Nonetheless, the role of autophagy in heart disease in the context of cardiac ischemia-reperfusion injury is currently unclear. This review will focus upon the role of autophagy as it pertains to ischemiareperfusion damage in the heart.
Export Options
About this article
Cite this article as:
Ghavami S., Gupta S., Ambrose E., Hnatowich M., Freed D.H. and Dixon I.M.C., Autophagy and Heart Disease: Implications for Cardiac Ischemia- Reperfusion Damage, Current Molecular Medicine 2014; 14 (5) . https://dx.doi.org/10.2174/1566524014666140603101520
DOI https://dx.doi.org/10.2174/1566524014666140603101520 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Inhibition of Candida rugosa Lipase by Different Extracts of Five Algerian Plants and their Antioxidant Activities
Current Enzyme Inhibition Lipoprotein Lipase and Atherosclerosis
Current Vascular Pharmacology Use of Chou’s 5-steps Rule to Study the Effect of Cereal Dietary Protein on Liver and Coronary Heart Disease Prevention
Current Nutrition & Food Science Hesperidin Potentiates Ghrelin Signaling
Recent Patents on Food, Nutrition & Agriculture Effects of Verbascoside Administration on the Blood Parameters and Oxidative Status in Jennies and Their Suckling Foals: Potential Improvement of Milk for Human Use
Endocrine, Metabolic & Immune Disorders - Drug Targets Drug Treatment of Metabolic Syndrome
Current Clinical Pharmacology Nutrigenetics, Metabolic Syndrome Risk and Personalized Nutrition
Current Vascular Pharmacology HPLC-DAD-Q-TOF/MS-Based Screening and Analysis of the Multiple Absorbed Bioactive Components in Rat Serum after Oral Administration of Xiexin Tang
Current Pharmaceutical Analysis Carotid Artery Atherosclerosis: What is the Evidence for Drug Action?
Current Pharmaceutical Design Is Bilirubin a Marker of Vascular Disease and/or Cancer and is it a Potential Therapeutic Target?
Current Pharmaceutical Design Global Cardiovascular Risk Management in Primary Prevention
Current Vascular Pharmacology Aspirin and Clopidogrel: A Sweeping Combination in Cardiology
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Mechanisms of Drug Induced QT Interval Prolongation
Current Drug Safety Patent Selections
Recent Patents on Biotechnology Cardioprotection with opioids - Trusted old friends -Clinical Science -
Current Pharmaceutical Design Antiplatelet Effects of Bioactive Compounds Present in Tomato Pomace
Current Drug Targets From Early Origins. When and Why does Asthma Develop?
Current Pediatric Reviews Are Sex Differences in Outcomes of Patients with ACS from Observational Registries Similar to the Findings from Randomized Clinical Trials?
Current Pharmaceutical Design Sleep in Pulmonary Hypertension
Current Respiratory Medicine Reviews Rationale of Statin Therapy in Septic Patients
Current Vascular Pharmacology